Targeting sleep and the circadian system as a novel treatment strategy for Parkinson's disease
Summary:
This paper discusses the potential of targeting sleep and the circadian system as a novel treatment strategy for Parkinson's disease, focusing on the role of the melanopsin containing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) and the circadian network in the disease.
Categories
- Dementia: The paper discusses the potential role of the circadian processes in neurodegenerative diseases like Parkinson's and Alzheimer's.
- Sleep and insomnia: The paper explores the wide range of sleep–wake disturbances that occur frequently in Parkinson's disease and the potential of targeting sleep and the circadian system as a treatment strategy.
- Cognitive function and memory: The paper discusses the impact of sleep and circadian disruptions on both motor and non-motor symptoms in Parkinson's disease, which could include cognitive function and memory.
- Aging: The paper discusses Parkinson's disease, a neurodegenerative disorder that primarily affects older adults.
- Phototherapy: The paper discusses the potential of using light therapy as a non-pharmacological strategy to reduce sleep disturbances in Parkinson's disease.
- Hormone regulation: The paper discusses the role of melatonin, a hormone that regulates sleep and wakefulness, in the circadian disruptions observed in Parkinson's disease.
Author(s)
B Feigl, SJG Lewis, O Rawashdeh
Publication Year:
2023
Number of Citations:
0
Related Publications
Dementia
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
Hormone regulation
- Phototransduction by retinal ganglion cells that set the circadian clock
- The impact of light from computer monitors on melatonin levels in college students
- Circadian rhythms–from genes to physiology and disease
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels